Search COVID-19

The TGA has granted a provisional determination to Moderna Australia Pty Ltd’s bivalent COVID-19 vaccine candidate: elasomeran and davesomeran (SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4/BA.5)

The TGA has provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, COMIRNATY (tozinameran), for children aged 6 months to less than 5 years

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has provisionally approved Pfizer's COVID-19 vaccine, COMIRNATY (tozinameran) for use as a booster dose in individuals 5 years to 11 years.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has approved the first two nasal combination self-tests (for use at home) that detect both COVID-19 and influenza viral infections in humans.

TGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults

Information about the TGA's safety monitoring of COVID-19 vaccines.

TGA grants provisional determination for sabizabulin for the treatment of COVID-19

The TGA approved Moderna Australia’s application to transition its COVID-19 vaccine, SPIKEVAX (elasomeran), from provisional to full registration.